Health Care Up on Legislative Optimism - Health Care Roundup

Shares of health-care companies rose amid optimism about the legislative outlook.

Drug maker Bristol-Myers Squibb could see a $1 billion sales boost from wider use of its cancer drug Opdivo after release of promising clinical-trial data, according to brokerage Leerink.

Federal prosecutors in Brooklyn asked a judge to prevent controversial pharma executive Martin Shkreli from making public commentary about his ongoing securities-fraud trial.

(-By Rob Curran,

(END) Dow Jones Newswires

July 05, 2017 16:24 ET (20:24 GMT)